EVHC:NYSE (USA) Also trade in: Germany

Envision Healthcare Corp

$ 45.99 0 (0%)
On watch
Volume: 0 Avg Vol (1m): 0
Market Cap $: 5.58 Bil Enterprise Value $: 10.27 Bil
P/E (TTM): 0.00 P/B: 1.21
Earnings Power Value 12.25
Net Current Asset Value -43.84
Tangible Book -38.46
Projected FCF 73.09
Median P/S Value 72.77
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 5/10

Current vs industry vs history
Cash-to-Debt 0.13
Equity-to-Asset 0.38
Debt-to-Equity 1.00
Debt-to-EBITDA 4.49
Interest Coverage 2.52
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.63
DISTRESS
GREY
SAFE
Beneish M-Score -2.15
Not Manipulator
Manipulator

Profitability & Growth : 7/10

Current vs industry vs history
Operating Margin % 7.85
Net Margin % -21.65
ROE % -29.05
ROA % -11.24
ROC (Joel Greenblatt) % 26.36
3-Year Total Revenue Growth Rate 68.90
3-Year Total EBITDA Growth Rate 35.40
3-Year EPS w/o NRI Growth Rate 18.70

» EVHC's 30-Y Financials

Financials (Next Earnings Date: 2019-05-02 Est.)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:EVHC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 621111    SIC : 8011
Compare BKK:BH NYSE:MD NYSE:CHE JSE:LHC JSE:NTC NAS:ACHC NYSE:AMN ASX:HSO NYSE:EHC XSGO:BANMEDICA SAU:4002 NYSE:THC NYSE:SEM NAS:LHCG NAS:AMED NSE:APOLLOHOSP XTER:RHK LSE:MDC ISX:MIKA NAS:LPNT
Traded in other countries N16.Germany
Address
AmSurg acquires and develops practice-based ambulatory surgery centers in partnership with physician groups. The company has a majority interest in 264 surgery centers in 35 states. AmSurg centers are typically single-specialty and perform procedures in the areas of gastroenterology, ophthalmology, and orthopedics.

Ratios

Current vs industry vs history
Forward PE Ratio 11.22
N/A
PB Ratio 1.21
PS Ratio 0.69
Price-to-Free-Cash-Flow 22.88
Price-to-Operating-Cash-Flow 12.69
EV-to-EBIT 16.07
EV-to-EBITDA 9.96
EV-to-Revenue 1.26
Current Ratio 2.44
Quick Ratio 2.42
Days Inventory 1.34
Days Sales Outstanding 69.18
Days Payable 3.60

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -36.00

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 0.63
Price-to-Median-PS-Value 0.63
Earnings Yield (Joel Greenblatt) % 6.22
Forward Rate of Return (Yacktman) % 11.98

More Statistics

Revenue (TTM) (Mil) $ 8,143.5
EPS (TTM) $ -14.56
Beta 0
Volatility % 33.76
52-Week Range $ 23.77 - 46
Shares Outstanding (Mil) 121.39

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N